New Haven, CT’s HistoRx, which is developing tissue-based diagnostics, announced it has closed a $6 million Series B funding round. The deal was led by Brook Venture Partners, and joined by Navigator Technology Ventures, The Roche Venture Fund, Commons Capital, and Maven Capital.
Sponsored · Whitepaper
What the most successful life sciences fundraising pitch decks all have in common
Brex
Sponsored · Whitepaper
Knowing the volume of procedures and growth trends by site of care can allow you to understand the market demand for your product
IBM Watson
From Our Editors · Special Report
Top biotech and investment players offer their best plans and current progress in stemming and ultimately defeating the worldwide pandemic
